ScriptSender, MedCurrent Corporation announce new partnership
ScriptSender, a West Palm Beach, Florida-based healthcare technology company, has partnered with Toronto-based MedCurrent Corporation to help its customers meet the CMS-mandated clinical decision support (CDS) guidelines scheduled to go into effect on Jan. 1, 2020.
As a result of the partnership, MedCurrent’s OrderWise CDS platform will be integrated into ScriptSender’s software suite. The OrderWise platform is a CMS-qualified clinical decision support mechanism, meaning referring physicians can use it for guidance as they order advanced imaging services.
“The legislative intent of CDS is to improve outcomes and reduce cost by leveraging evidence-based standards,” Chris Craft, CEO of ScriptSender, said in a prepared statement. “With the January 1st, 2020, deadline quickly approaching, physicians need a solution, and they need it fast. ScriptSender and MedCurrent enable groups to be compliant on day one—ahead of the competition.”
“This relationship means that clinicians who use ScriptSender now have access to a CMS-qualified clinical decision support mechanism,” John Adziovsky, CEO of MedCurrent, said in the same statement. “It makes it so easy for providers to optimize their clinical workflow, facilitate more appropriate care, and meet regulatory requirements. Patients receive evidence-based care and clinicians benefit from improved clinical and operational outcomes. This is what technology should be doing for healthcare, and we're very excited to be working together with ScriptSender to make this happen.”
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.